3rd Quarter - Report
WILLIAMS AND JENSEN, PLLC for BAYER CORPORATION
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug safety and drug counterfeiting (track and trace); Drug importation; 340B Program; Authorized generics; Prescription drug advertising; Federal preemption for prescription drugs; Implementation of Patient Protection and Affordable Care Act; drug shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BEER New | LA, Rep. Dave Hobson |
| JENNY DIJAMES New | LA and LD, Rep. Bud Cramer |
| JACK STEVEN HART | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| MELINDA M MAXFIELD | — |
| ERIN BOOK MULLEN New | — |
| GEORGE OLSEN | — |
Medicare/Medicaid MMM
Medicare payment for diabetes testing strips; drug rebates for Medicare Part D. Independent Payment Advisory Board (IPAB). House and Senate Budget resolutions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.